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Abstract Obesity is well established as a cause of post-
menopausal breast cancer incidence and mortality. In
contrast, adiposity in early life reduces breast cancer inci-
dence. However, whether short-term weight change influ-
ences breast cancer risk is not well known. We followed a
cohort of 77,232 women from 1980 to 2006 (1,445,578
person-years), with routinely updated risk factor informa-
tion, documenting 4196 incident cases of invasive breast
cancer. ER and PR status were obtained from pathology
reports and medical records yielding a total of 2033 ER?/
PR? tumors, 595 ER-/PR- tumors, 512 ER?/PR- tu-
mors. The log incidence breast cancer model was used to
assess the association of short-term weight gain (over past
4 years) while controlling for average BMI before and after
menopause. Short-term weight change was significantly
associated with breast cancer risk (RR 1.20; 95 %
CI 1.09–1.33) for a 4-year weight gain of C15 lbs versus
no change (B5 lbs) (P_trend \ 0.001). The association
was stronger for premenopausal women (RR 1.38; 95 %
CI 1.13–1.69) (P_trend = 0.004) than for postmenopausal
women (RR 1.10; 95 % CI 0.97–1.25) (P_trend = 0.063).
Short-term weight gain during premenopause had a stron-
ger association for ER?/PR- (RR per 25 lb weight
gain = 2.19; 95 % CI 1.33–3.61, P = 0.002) and ER-/
PR- breast cancer (RR per 25 lb weight gain = 1.61;
95 % CI 1.09–2.38, P = 0.016) than for ER?/PR? breast
cancer (RR per 25 lb weight gain = 1.13; 95 %
CI 0.89–1.43, P = 0.32). There are deleterious effects of
short-term weight gain, particularly during pre-menopause,
even after controlling for average BMI before and after
menopause. The association was stronger for ER?/PR-
and ER-/PR- than for ER?/PR? breast cancer.
Keywords Breast cancer risk  Hormone receptor
classification  Obesity  BMI
Obesity is established as a cause of postmenopausal breast
cancer incidence and mortality [1, 2]. Furthermore, adi-
posity in early life—through the premenopausal years—
reduces breast cancer incidence [3, 4]. This was observed
for adiposity at ages 5 and 10 [4]. The Carolina breast
cancer study [5] shows this association in White but not
Black women for premenopausal breast cancer. The
French E3 N cohort [6] shows an inverse trend for larger
body shape at age 8 that is not significant for pre-
menopausal breast cancer though they had far fewer cases
than in their postmenopausal women where the trend was
significant Among premenopausal women body shape 4?
had HR 0.88 (0.79, 0.98) compared to the leanest women
at age 8. Among postmenopausal women, the trend was
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significantly inverse for ER? and significantly positive for
ER-PR-. Slattery et al. [7] analyzing the New Mexico
region case control study, using BMI at age 15, reported a
strongly inverse association for girls with heavier figures
but the trend was not significant. BMI at age 15 [ 22.5
had an RR 0.68 (0.44, 1.04) for non-Hispanic white
women, and 0.65 (0.39, 1.08) for Hispanic premenopausal
breast cancer. Berstad et al. [8] used body shapes at me-
narche in their case control study. They report a significant
inverse trend for postmenopausal but non-significant in-
verse trend for premenopausal breast cancer (based on
2089 cases with reported body figure at menarche). Wei-
derpass [9] has prospective data from Norway and Sweden
with 733 invasive premenopausal breast cancers. Body
shape at age 7 was used. They control for both BMI at 18
and adult BMI and reported inverse associations for
heavier girls at age 7, though not a significant trend. These
inverse associations persists across categories of BMI at
cohort entry.
Studies using measures of adiposity at age 18 also re-
port inverse relations with premenopausal breast cancer
[10] and for some but not all molecular subtypes of breast
cancer [11]. Prospective studies of weight gain from early
adult years (ages 18–25) to mid-life, show positive asso-
ciations with risk of postmenopausal breast cancer [12–
20], and support the conclusion that long term adult
weight gain increases risk of postmenopausal breast cancer
[21]. However, Tamimi et al. [11] show significant
heterogeneity of effects of weight gain since age 18 by
histologic type. European data further suggested that
weight gain in middle adulthood, over an average of
4.3 years, is related to subsequent risk of breast cancer
over 7.5 years of follow-up. The association is stronger
among women under age 50, though only 283 cases were
premenopausal and diagnosed before age 50 [22]. Other
studies of weight gain among women in their 40s have
related weight gain to risk of postmenopausal breast can-
cer [12, 23], or have combined pre- and postmenopausal
cases [24].
Although Nurses’ Health Study data show weight loss
after menopause is related to reduced incidence of breast
cancer [12], the temporal relation between childhood and
adolescent weight, weight gain, and risk of breast cancer
both before and after menopause is not well defined. The
validated Rosner-Colditz breast cancer incidence model
evaluates risk factors across the life course integrating
exposures updated every 2 years, [25, 26]. This model,
therefore, offers a unique opportunity to assess the relations
of recent changes in weight, in relation to total pre- and
postmenopausal invasive breast cancer, and subtype de-
fined by receptor status while controlling for average BMI
before and after menopause.
Methods
Methods of procedure and description of model
The Nurses’ Health Study was established in 1976 when
121, 701 female US registered nurses ages 30–55 re-
sponded to a mail questionnaire inquiring about risk factors
for breast cancer including reproductive factors, hormone
use, anthropometric variables, benign breast disease
(BBD), and family history of breast cancer. The risk factors
have been updated by questionnaires every 2 years up to
the present time [27]. Alcohol consumption both currently
and at age 18 was ascertained in 1980, updated in 1984,
and every 4 years from 1986 to 2006. Weight at age 18 was
ascertained in 1980. Hence, follow-up for this analysis
began in 1980.
Identification of breast cancer cases
On each questionnaire, women were asked whether breast
cancer had been diagnosed, and if so, the date of diagnosis.
All women (or the next of kin, if deceased) were contacted
for permission to review their medical records so as to
confirm the diagnosis. Pathology reports were also re-
viewed to obtain information on estrogen (ER), and pro-
gesterone (PR) receptor status. Cases of invasive breast
cancer from 1980–2006 were included in the primary
analysis.
Cases for which we had a pathology report were in-
cluded in these analyses. We excluded women with type of
menopause other than natural or bilateral oophorectomy,
prevalent cancer (other than non-melanoma skin cancer) in
1980, or missing data for weight at age 18, age at first birth,
parity, age at menarche, age at menopause or hormone use.
Thus, overall, 77,232 women were followed over 1,445,578
person-years from 1980 to 2006 during which 4196 inci-
dent invasive cases of breast cancer occurred. ER and PR
status were obtained from pathology reports and medical
records. A total of 2033 ER?/PR?, 595 ER-/PR-, and
512 ER?/PR- tumors were identified among women with
complete breast cancer risk factor information. (See Online
Resource 1 for breakdown by receptor type and meno-
pausal status). 964 breast cancer cases with missing ER
and/or PR status were censored at the time of diagnosis.
For the primary analysis (Tables 2, 3), all incident breast
cancers were included including the 964 breast cancer
cases with missing ER/PR subtype. For the tumor subtype
analysis (Table 4) (e.g., for ER?/PR? breast cancer),
cases for other subtypes (e.g., ER?/PR- or ER-/PR-
cases) or cases missing ER/PR subtypes were treated as
censored events (i.e., competing risks). There were 92
women who developed ER-/PR? breast cancer. These
644 Breast Cancer Res Treat (2015) 150:643–653
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women were also considered as missing ER/PR status and
censored at the time of diagnosis because in a subset of 71
women initially classified as ER-/PR?, only 4 (6 %) were
confirmed as ER-/PR? by TMA classification.
Statistical analysis
Description of the log-incidence model of breast cancer
We assume that the incidence of breast cancer at time t (It)
is proportional to the number of cell divisions (Ct) accu-
mulated up to age t (i.e., It = KCt). Ct is obtained from
Ct ¼ Co 
Yt1
i¼0
ðCiþ1=CiÞ ¼ Co 
Yt1
i¼0
ki ð1Þ
Thus, ki = Ci?1/Ci = the rate of increase in Ct from age i
to age i ? 1. Log (ki) is assumed to be a linear function of
risk factors that are relevant at age i. The set of relevant
risk factors and their magnitude and/or direction may vary
by stage of reproductive life. Since the complete set of
relevant risk factors at time t is unknown, we generalize
Eq. 1 by substituting h0(t) for k which allows for the ex-
istence of other risk factors which accumulate over time.
The overall Cox regression model is given by
hðtjxÞ ¼ hoðtÞ expðbxÞ ð2Þ
where ho(t) = baseline hazard.
Details of the model have been described elsewhere [25,
26, 28]. Two variables in the model that were controlled for in
the present analyses were average BMI pre-menopause and
average BMI post-menopause with the latter computed
separately for person-time when a women was or was not on
HRT. All variables in the model were updated every 2 years.
The risk factors in Eq. 2 were updated every 2 years and
analyzed as time-dependent covariates using the Cox pro-
portional hazards model with an Anderson-Gill data structure.
To the model, we added terms for weight change over
4 years and then separately by menopausal status where
women were premenopausal at both measures of weight, or
postmenopausal at both measures of weight. 4-year weight
change was updated at each questionnaire cycle (every
2 years) and used to predict breast cancer incidence over
the next 2 years. Some women who were pre-menopausal
over the 4-year weight change period may have become
post-menopausal over the subsequent 2 years, but were
included in the menopause-status-specific analyses.
Measures, weight, height, time of measure and validity
or reproducibility
Self-reported weight in this cohort was shown to be
strongly related to measured weight (r = 0.97) [29], with
mean difference of (self-reported weight minus measured
weight 6–12 months later = 1.5 kg) [30]. Validity of re-
called weight at age 18 was assessed in younger nurses and
compared against nursing school admission physical exam
records showing a mean difference between self-report and
recorded weights of 1.4 kg. The correlation between re-
called and recorded weights was 0.87, and was indepen-
dent of current age [31].
The correlations among weights are summarized in
Online Resource 2. Weight at age 18 has a low correlation
with long-term weight change among premenopausal
(r = -0.11) and post-menopausal (r = -0.03) women.
Short-term weight change was moderately correlated with
long-term weight change for both pre-menopausal
(r = 0.39) and postmenopausal (r = 0.52) women.
Menopausal status and post-menopausal hormone
use
As reported previously [32], menopause is assessed on
each follow-up questionnaire (http://www.channing.har
vard.edu/nhs/questionnaires/index.shtml). A woman is
asked, ‘‘Have your periods ceased permanently?’’ If yes,
‘‘Have you had either of your ovaries removed?’’ If yes,
‘‘How many remain (none; one)?’’ In the present analysis,
person-time is only included for either pre-menopausal
women or post-menopausal women with natural meno-
pause or bilateral oophorectomy. Women with other types
of menopause are censored at the time of menopause.
We defined the type of hormone therapy used on the
basis of the response to follow-up questionnaires each
2 years. Women indicated that whether they used conju-
gated estrogens or progestin and, if so, the dose of estrogen
and progestin used. They also indicated that whether they
used hormones continuously or if they stopped estrogen for
7 days per month or used progestin for only 10–14 days
per month or continuously.
Missing data issues
Weights for subjects that were missing at a specific ques-
tionnaire were carried forward from one previous ques-
tionnaire but were set to missing after this.
Model sequence
First, models were run for breast cancer on 4-year weight
change overall (model 1, Table 2) after controlling for
standard breast cancer risk factors. Second, we ran addi-
tional models with cross-product terms of 4-year weight
change 9 menopausal status (models 2 and 3, Table 2) in
addition to the main effect of menopausal status. Third, we
subdivided post-menopausal women by postmenopausal
Breast Cancer Res Treat (2015) 150:643–653 645
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hormone use status (PMH) at age t and t - 4 and intro-
duced interaction terms of 4-year weight change by PMH
(models 4 and 5, Table 2). Fourth, we explored whether the
effect of weight change varied according to initial BMI at
time t - 4 (\25/C25) both overall and by menopausal
status (Table 3). Fifth, we looked at whether effects of
weight change varied by tumor subtype (ER?/PR?, ER?/
PR-, ER-/PR-) (Table 4). In Tables 1, 2, 3, and 4, we
controlled for long-term weight profiles using average BMI
pre- and post-menopause in Eq. 2.
Results
Risk factors by weight change status (Table 1)
At the midpoint of follow-up (1994) the established risk
factors for breast cancer varied modestly across categories
of weight change (see Table 1). However, women with
greater 4–year weight gain were on average younger, and
more likely to be premenopausal (18 vs. 12 % among
women with no weight change over 4 years).
Weight change over 4 years and incidence of breast
cancer (Table 2)
We first fit weight change over 4 years to the full model
adjusting for risk factors across the life course. Weight
change is presented in categories of weight change and
relative risks are compared to women with B5 lb change.
Overall, the relative risk of breast cancer was 1.20 (95 %
CI 1.09, 1.33) for women with C15 lb weight gain com-
pared to women with no change. The overall mean 4-year
weight change was 2.56 lb. The difference between the
10th and 90th percentiles for weight change was 25
pounds. The relative risk ofbreast cancer for this magnitude
of weight gain in 4 years was 1.13 (95 % CI 1.06, 1.21).
We next assessed risk among women who were pre-
menopausal and postmenopausal respectively at both time
points (see Table 2, models 2 and 3). Among pre-
menopausal women, mean weight gain = 4.59 lbs with 736
incident cases of breast cancer. The RR per 25 lbs weight
gain was 1.26 (1.08, 1.48). Women who gained C15 lb in
4-years had a RR of 1.38 (1.13, 1.69) compared to women
with no change. Among postmenopausal women, mean
weight gain = 1.41 pounds. The RR per 25 lbs weight gain
was 1.08 (1.00, 1.16); and the RR for a gain of C15 lb
versus no change was 1.10 (0.97, 1.25). See Fig. 1. Asso-
ciations with 4-year weight gain among postmenopausal
women were similar for current and never postmenopausal
hormone users (Table 2, models 4 and 5).
Weight gain and breast cancer risk stratified
by baseline BMI (Table 3)
We next evaluated the association for weight gain by strata
of baseline BMI (\25/C25 kg/m2). Leaner women gained
more weight than overweight and obese women. The
overall association for weight gain was stronger among
lean women (RR = 1.26 for 25 lb weight change) than
among overweight and obese (RR = 1.09) phet = 0.04
(see Table 3). Among postmenopausal women, the asso-
ciation did not differ by baseline BMI. However, among
premenopausal women the association for weight change
over 4-years and breast cancer risk was significantly
stronger among those who were normal weight at baseline
(RR 1.65 vs. 1.02 for 25 lb weight change phet \ 0.001)
(see Fig. 2), and similarly for weight gain of C15 lb versus
no change.
Weight change and tumor characteristics (Table 4)
We next assessed weight gain over 4 years and breast
cancer defined by hormone receptor status (Table 4). This
analysis included 3140 cases for whom receptor status was
available. For the 2033 incident cases of ER?/PR? breast
cancer, weight gain showed an overall positive association
(RR 1.10; 1.00, 1.20) for a 25 lb weight change. For
women gaining C15 lb compared to those with no change
the RR was 1.16 (1.00, 1.34). For ER?/PR- breast cancer,
the overall association for a 25 lb change was stronger
(1.36; 1.13, 1.64), phet = 0.04. The association was not
different for the ER-/PR- cases (RR 1.09; 0.91, 1.31)
compared to the ER?/PR? association. Examining these
associations among pre- and postmenopausal women
separately, we observed that short-term weight gain during
premenopause had a stronger association for ER?/PR-
(RR per 25 lb weight gain = 2.19; 95 % CI 1.33–3.61,
P = 0.002) and ER-/PR- breast cancer (RR per 25 lb
weight gain = 1.61; 95 % CI 1.09–2.38, P = 0.016) than
for ER?/PR? breast cancer (RR per 25 lb weight
gain = 1.13; 95 % CI 0.89–1.43, P = 0.32). Weight gain
C15 lb showed a similar pattern. Among postmenopausal
women, the strongest associations were observed for the
ER? PR- cases (RR 1.25; 1.01, 1.54) per 25 lb weight
gain.
BMI
We repeated the analyses using BMI as the measure of
change and results remained unchanged. Likewise, when
using other analytic structures including Poisson regres-
sion, results were comparable.
646 Breast Cancer Res Treat (2015) 150:643–653
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Table 1 Comparison of breast cancer risk factors in 1994 by weight change from 1990 to 1994, Nurses’ Health Study, n = 45,009 women
Variable 4-year weight change group
Wt loss of
[5 lbs
(n = 5, 610)
No changea
(n = 22,202)
Wt gain of
5.1–9.9 lbs
(n = 5207)
Wt gain of
10.0–14.9 lbs
(n = 5732)
Wt gain of
C15.0 lbs
(n = 6258)
Age (years) 61.8 60.8 59.6 58.8 57.9
Mean
Age at menarche (years) 12.5 12.6 12.6 12.5 12.4
Mean
Pre-menopausal 9 12 14 17 18
%
Age at menopause (years)c 48.7 48.9 48.8 48.6 48.3
Mean
Natural menopause c 79 80 79 77 76
%
Age at 1st birth (years)b 25.5 25.3 25.1 25.0 24.9
Mean
Parity 6 6 6 5 6
0 (%)
1 (%) 8 7 7 7 7
2 (%) 28 28 29 30 31
3 (%) 26 28 29 28 28
4? (%) 31 31 30 30 28
Mean 3.0 3.0 2.9 2.9 2.9
Birth index 61.0 62.5 62.5 62.0 61.0
Mean
Weight at age 18 (lb) 130.7 124.1 123.3 126.2 131.8
Mean
Current weight (lb) 153.2 147.1 152.4 164.5 185.4
Mean
Height (in) 64.7 64.4 64.4 64.6 64.9
Mean
Alcohol intake (gm) 4.3 5.3 5.4 4.9 4.3
Mean
Current pmh use 35.9 43.6 45.5 44.2 44.1
%
Past pmh use 24.4 21.4 21.4 21.8 21.2
%
Duration of estrogen use (years) 2.1 2.2 2.0 2.0 1.9
Mean
Duration of E?P use (years) 0.8 1.1 1.1 1.0 1.0
Mean
Benign breast disease 42 45 49 47 47
%
Family Hx of breast cancer 12 13 13 12 12
%
pmh postmenopausal hormones, E?P estrogen and progesterone
a Weight change of B5 lbs
b Parous women
c Among postmenopausal women
Breast Cancer Res Treat (2015) 150:643–653 647
123
T
a
b
le
2
E
ff
ec
t
o
f
w
ei
g
h
t
ch
an
g
e
o
v
er
p
as
t
4
y
ea
rs
o
n
in
ci
d
en
ce
o
f
b
re
as
t
ca
n
ce
r,
N
u
rs
es
’
H
ea
lt
h
S
tu
d
y
,
1
9
8
0
–
2
0
0
6
,
4
1
9
6
ca
se
s,
1
,4
4
5
,5
7
8
p
er
so
n
-y
ea
rs
M
o
d
el
G
ro
u
p
M
ea
n
(s
d
)c
(1
0
–
9
0
%
)d
N
u
m
b
er
o
f
ca
se
s
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
(l
b
s)
L
o
ss
o
f
[
5
lb
s
N
o
ch
an
g
ea
(r
ef
)
G
ai
n
o
f
5
.1
–
9
.9
lb
s
G
ai
n
o
f
1
0
.0
–
1
4
.9
lb
s
G
ai
n
o
f
C
1
5
.0
lb
s
R
R
(p
er
2
5
lb
s
w
t
g
ai
n
)
P
_
tr
en
d
1
O
v
er
al
l
2
.5
6
(1
1
.8
9
)
(-
1
0
,
1
5
)
4
1
9
6
0
.9
7
(0
.8
9
–
1
.0
7
)
1
.0
1
.0
5
(0
.9
4
–
1
.1
6
)
1
.0
9
(0
.9
8
–
1
.2
0
)
1
.2
0
(1
.0
9
–
1
.3
3
)
1
.1
3
(1
.0
6
–
1
.2
1
)
\
0
.0
0
1
2
P
re
-m
en
o
p
au
sa
lb
4
.5
9
(1
1
.6
0
)
(-
6
,
1
7
)
7
3
6
1
.0
2
(0
.7
9
–
1
.3
2
)
1
.0
0
.9
8
(0
.7
7
–
1
.2
5
)
1
.1
0
(0
.8
8
–
1
.3
8
)
1
.3
8
(1
.1
3
–
1
.6
9
)
1
.2
6
(1
.0
8
–
1
.4
8
)
0
.0
0
4
3
P
o
st
-m
en
o
p
au
sa
lb
1
.4
1
(1
1
.8
3
)
(-
1
0
,
1
4
)
3
0
0
9
0
.9
8
(0
.8
8
–
1
.0
8
)
1
.0
1
.0
5
(0
.9
3
–
1
.1
9
)
1
.0
6
(0
.9
4
–
1
.2
0
)
1
.1
0
(0
.9
7
–
1
.2
5
)
1
.0
8
(1
.0
0
–
1
.1
6
)
0
.0
6
3
4
C
u
rr
en
t
p
m
h
b
2
.2
4
(1
0
.7
6
)
(-
9
,
1
4
)
1
0
6
8
0
.9
9
(0
.8
3
–
1
.1
8
)
1
.0
1
.1
8
(0
.9
8
–
1
.4
3
)
0
.9
4
(0
.7
5
–
1
.1
7
)
1
.1
6
(0
.9
4
–
1
.4
3
)
1
.1
0
(0
.9
5
–
1
.2
8
)
0
.1
8
5
N
o
p
m
h
b
1
.1
3
(1
2
.2
3
)
(-
1
1
,
1
4
)
1
4
7
5
0
.9
6
(0
.8
3
–
1
.1
0
)
1
.0
0
.9
9
(0
.8
2
–
1
.1
9
)
1
.1
6
(0
.9
8
–
1
.3
8
)
1
.0
4
(0
.8
7
–
1
.2
5
)
1
.0
7
(0
.9
7
–
1
.1
9
)
0
.1
9
U
si
n
g
p
ro
c
p
h
re
g
o
f
S
A
S
p
m
h
p
o
st
m
en
o
p
au
sa
l
h
o
rm
o
n
es
a
W
ei
g
h
t
ch
an
g
e
o
f
B
5
lb
s
b
A
t
b
o
th
ti
m
e
t
an
d
ti
m
e
t
-
4
c
M
ea
n
(s
d
)
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
d
1
0
–
9
0
p
er
ce
n
ti
le
o
f
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
648 Breast Cancer Res Treat (2015) 150:643–653
123
T
a
b
le
3
E
ff
ec
t
o
f
w
ei
g
h
t
ch
an
g
e
o
v
er
4
y
ea
rs
o
n
in
ci
d
en
ce
o
f
b
re
as
t
ca
n
ce
r,
N
u
rs
es
’
H
ea
lt
h
S
tu
d
y
,
1
9
8
0
–
2
0
0
6
,
4
1
9
6
ca
se
s,
1
,4
4
5
,5
7
8
p
er
so
n
-y
ea
rs
st
ra
ti
fi
ed
b
y
in
it
ia
l
B
M
I
at
b
eg
in
n
in
g
o
f
4
-y
ea
r
p
er
io
d
In
it
ia
l
B
M
I
at
ti
m
e
t
-
4
G
ro
u
p
M
ea
n
(s
d
)e
(1
0
–
9
0
%
)f
N
u
m
b
er
o
f
ca
se
s
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
(l
b
s)
L
o
ss
o
f
[
5
lb
s
N
o
ch
an
g
ea
(r
ef
)
G
ai
n
o
f
5
.1
–
9
.9
lb
s
G
ai
n
o
f
1
0
.0
–
1
4
.9
lb
s
G
ai
n
o
f
C
1
5
.0
lb
s
R
R
(p
er
2
5
lb
s
w
t
g
ai
n
)
P
_
tr
en
d
P
_
h
et
b
\
2
5
O
v
er
al
l
3
.2
6
(8
.7
6
)
(-
5
,1
3
)
2
2
3
5
0
.9
3
(0
.8
0
–
1
.0
8
)
1
.0
1
.0
5
(0
.9
2
–
1
.2
0
)
1
.1
2
(0
.9
8
–
1
.2
9
)
1
.2
4
(1
.0
7
–
1
.4
4
)
1
.2
6
(1
.1
3
–
1
.4
1
)
\
0
.0
0
1
0
.0
4
0
P
re
-m
en
o
p
au
sa
lc
4
.5
1
(8
.4
9
)
(-
4
,1
5
)
5
3
2
0
.8
8
(0
.5
9
–
1
.3
0
)
1
.0
1
.1
2
(0
.8
6
–
1
.4
4
)
1
.3
3
(1
.0
4
–
1
.7
0
)
1
.4
2
(1
.0
9
–
1
.8
5
)
1
.6
5
(1
.3
5
–
2
.0
2
)
\
0
.0
0
1
\
0
.0
0
1
P
o
st
-m
en
o
p
au
sa
ld
2
.2
9
(8
.8
0
)
(-
7
,1
2
)
1
4
3
7
0
.9
7
(0
.8
2
–
1
.1
4
)
1
.0
1
.0
0
(0
.8
5
–
1
.1
8
)
1
.0
0
(0
.8
3
–
1
.2
1
)
1
.1
0
(0
.9
0
–
1
.3
5
)
1
.0
9
(0
.9
4
–
1
.2
6
)
0
.2
7
0
.9
9
C
2
5
O
v
er
al
l
1
.6
2
(1
5
.0
2
)
(-
1
5
,1
8
)
1
9
6
1
0
.9
6
(0
.8
6
–
1
.0
8
)
1
.0
1
.0
5
(0
.8
9
–
1
.2
5
)
1
.0
3
(0
.8
9
–
1
.1
9
)
1
.1
6
(1
.0
1
–
1
.3
2
)
1
.0
9
(1
.0
1
–
1
.1
8
)
0
.0
2
7
–
P
re
-m
en
o
p
au
sa
lc
4
.7
8
(1
6
.6
3
)
(-
1
3
,2
3
)
2
0
4
1
.0
4
(0
.7
5
–
1
.4
4
)
1
.0
0
.4
9
(0
.2
4
–
0
.9
9
)
0
.6
6
(0
.4
3
–
1
.0
2
)
1
.2
6
(0
.9
6
–
1
.6
7
)
1
.0
2
(0
.8
3
–
1
.2
5
)
0
.8
4
–
P
o
st
-m
en
o
p
au
sa
ld
0
.4
9
(1
4
.2
9
)
(-
1
5
,1
5
)
1
5
7
2
0
.9
6
(0
.8
5
–
1
.0
9
)
1
.0
1
.1
3
(0
.9
4
–
1
.3
5
)
1
.0
9
(0
.9
3
–
1
.2
9
)
1
.1
0
(0
.9
3
–
1
.2
9
)
1
.0
9
(0
.9
9
–
1
.1
9
)
0
.0
7
4
–
U
si
n
g
p
ro
c
p
h
re
g
o
f
S
A
S
a
w
ei
g
h
t
ch
an
g
e
o
v
er
4
y
ea
rs
o
f
B
5
lb
s
b
co
m
p
ar
in
g
R
R
p
er
2
5
lb
w
ei
g
h
t
g
ai
n
fo
r
in
it
ia
l
B
M
I
\
2
5
v
er
su
s
in
it
ia
l
B
M
I
C
2
5
c
p
re
m
en
o
p
au
sa
l
at
b
o
th
ag
e
t
an
d
ag
e
t
-
4
d
p
o
st
m
en
o
p
au
sa
l
at
b
o
th
ag
e
t
an
d
ag
e
t
-
4
e
m
ea
n
(s
d
)
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
f
(1
0
–
9
0
p
er
ce
n
ti
le
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e)
Breast Cancer Res Treat (2015) 150:643–653 649
123
T
a
b
le
4
E
ff
ec
t
o
f
w
ei
g
h
t
ch
an
g
e
o
v
er
p
as
t
4
y
ea
rs
o
n
in
ci
d
en
ce
o
f
b
re
as
t
ca
n
ce
r,
b
y
tu
m
o
r
su
b
ty
p
e,
N
u
rs
es
’
H
ea
lt
h
S
tu
d
y
,
1
9
8
0
–
2
0
0
6
,
3
1
4
0
ca
se
s,
1
,4
4
5
,5
7
8
p
er
so
n
-y
ea
rs
S
u
b
ty
p
e
G
ro
u
p
N
u
m
b
er
o
f
ca
se
s
4
-y
ea
r
w
ei
g
h
t
ch
an
g
e
(l
b
s)
L
o
ss
o
f
[
5
lb
s
N
o
ch
an
g
ea
(r
ef
)
G
ai
n
o
f
5
.1
–
9
.9
lb
s
G
ai
n
o
f
1
0
.0
–
1
4
.9
lb
s
G
ai
n
o
f
C
1
5
.0
lb
s
R
R
(p
er
2
5
lb
s
w
t
g
ai
n
)
P
_
tr
en
d
P
_
h
et
b
E
R
?
/P
R
?
O
v
er
al
l
2
0
3
3
0
.9
5
(0
.8
4
–
1
.0
8
)
1
.0
1
.0
4
(0
.8
9
–
1
.2
0
)
1
.0
6
(0
.9
2
–
1
.2
3
)
1
.1
6
(1
.0
0
–
1
.3
4
)
1
.1
0
(1
.0
0
–
1
.2
0
)
0
.0
5
0
–
P
re
m
en
o
p
au
sa
lc
3
1
6
0
.9
4
(0
.6
3
–
1
.4
0
)
1
.0
0
.9
2
(0
.6
3
–
1
.3
4
)
1
.1
6
(0
.8
3
–
1
.6
1
)
1
.2
7
(0
.9
3
–
1
.7
3
)
1
.1
3
(0
.8
9
–
1
.4
3
)
0
.3
2
–
P
o
st
m
en
o
p
au
sa
ld
1
5
1
8
0
.9
6
(0
.8
4
–
1
.1
0
)
1
.0
1
.0
3
(0
.8
7
–
1
.2
3
)
1
.0
1
(0
.8
4
–
1
.2
1
)
1
.0
6
(0
.8
8
–
1
.2
7
)
1
.0
5
(0
.9
4
–
1
.1
6
)
0
.4
0
–
E
R
?
/P
R
-
O
v
er
al
l
5
1
2
0
.7
2
(0
.5
5
–
0
.9
5
)
1
.0
1
.1
8
(0
.9
0
–
1
.5
5
)
0
.7
9
(0
.5
7
–
1
.0
9
)
1
.0
7
(0
.7
9
–
1
.4
5
)
1
.3
6
(1
.1
3
–
1
.6
4
)
0
.0
0
1
0
.0
4
0
P
re
m
en
o
p
au
sa
lc
4
2
1
.3
4
(0
.5
0
–
3
.5
8
)
1
.0
1
.1
1
(0
.4
1
–
2
.9
5
)
0
.6
0
(0
.1
8
–
1
.9
9
)
1
.7
7
(0
.8
0
–
3
.8
9
)
2
.1
9
(1
.3
3
–
3
.6
1
)
0
.0
0
2
0
.0
1
9
P
o
st
m
en
o
p
au
sa
ld
4
1
9
0
.7
3
(0
.5
4
–
0
.9
7
)
1
.0
1
.2
1
(0
.9
0
–
1
.6
4
)
0
.8
0
(0
.5
5
–
1
.1
4
)
0
.9
1
(0
.6
3
–
1
.3
0
)
1
.2
5
(1
.0
1
–
1
.5
4
)
0
.0
4
3
0
.1
5
E
R
-
/P
R
-
O
v
er
al
l
5
9
5
1
.3
2
(1
.0
5
–
1
.6
5
)
1
.0
1
.0
5
(0
.7
9
–
1
.4
0
)
1
.4
3
(1
.1
1
–
1
.8
3
)
1
.2
3
(0
.9
4
–
1
.6
2
)
1
.0
9
(0
.9
1
–
1
.3
1
)
0
.3
4
0
.9
7
P
re
m
en
o
p
au
sa
lc
1
0
0
1
.0
7
(0
.5
0
–
2
.2
9
)
1
.0
1
.1
3
(0
.5
7
–
2
.2
6
)
2
.1
0
(1
.2
3
–
3
.5
6
)
2
.0
6
(1
.2
1
–
3
.5
1
)
1
.6
1
(1
.0
9
–
2
.3
8
)
0
.0
1
6
0
.1
2
P
o
st
m
en
o
p
au
sa
ld
4
1
9
1
.3
6
(1
.0
6
–
1
.7
5
)
1
.0
1
.0
0
(0
.7
0
–
1
.4
1
)
1
.3
9
(1
.0
2
–
1
.9
0
)
1
.0
1
(0
.7
0
–
1
.4
6
)
0
.9
9
(0
.8
0
–
1
.2
3
)
0
.9
3
0
.6
5
U
si
n
g
p
ro
c
p
h
re
g
o
f
S
A
S
E
R
es
tr
o
g
en
re
ce
p
to
r,
P
R
p
ro
g
es
te
ro
n
e
re
ce
p
to
r
a
W
ei
g
h
t
ch
an
g
e
o
v
er
4
y
ea
rs
o
f
B
5
lb
s
b
C
o
m
p
ar
in
g
R
R
p
er
2
5
lb
w
ei
g
h
t
g
ai
n
v
er
su
s
E
R
?
/P
R
?
c
P
re
m
en
o
p
au
sa
l
at
b
o
th
ag
e
t
an
d
ag
e
t
-
4
d
P
o
st
m
en
o
p
au
sa
l
at
b
o
th
ag
e
t
an
d
ag
e
t
-
4
650 Breast Cancer Res Treat (2015) 150:643–653
123
Discussion
In these detailed prospective data with repeated measures
of weight across the life course, weight gain over 4-years
was positively associated with overall breast cancer risk,
and was most strongly associated with premenopausal
breast cancer. Short-term weight gain in premenopausal
years also carries risk for ER?/PR- and ER-/PR-
disease.
These data support a report from Mexico where trajec-
tories of weight gain showed increased risk of pre-
menopausal and postmenopausal breast cancer; increasing
adiposity from age 8 was positively related to increased
risk [33]. That study, however, did not have repeated
measures and could not separate out short-term and long-
term weight change. Other prospective studies have fo-
cused on long term or mid-life weight gain and risk of
postmenopausal breast cancer [12–15, 24].
The current data confirm findings that reported from the
EPIC-PANACEA study, which showed a positive relation
between weight gain over an average of 4.3 years and risk
for breast cancer during 7.5 years of follow-up [22]. EPIC
had a weight gain in the top quintile of 1.33 kg/year, on
average, representing a gain of approximately 11.7 pounds
over 4 years, comparable to our category of 10–14.9
pounds. The association was stronger among women di-
agnosed under age 50. We have substantially more cases of
premenopausal breast cancer and replicate that association.
That study showed no heterogeneity according to receptor
status among cases diagnosed after age 50. The EPIC re-
sults stratified by hormone therapy showed no modification
of the association after age 50. Our results for short-term
weight gain are consistent with this result. However, EPIC
did not find a significant interaction between weight change
and initial BMI (B25 vs.[25) for either cases diagnosed at
B50 or [50, contrary to our finding of a significant inter-
action for pre-menopausal women. However, the number
of cases in EPIC diagnosed at B50 years with initial BMI
[25 was small.
Fig. 1 Hazard ratio of incident breast cancer by 4-year weight
change. Loss weight loss of[5 lbs, No change weight gain or weight
loss of B5 lbs, Small weight gain of 5.1–9.9 lbs, Moderate weight
gain of 10.0–14.9 lbs, Large weight gain of C15.0 lbs
Fig. 2 Hazard ratio of incident
breast cancer by 4-year weight
change stratified by initial BMI.
Loss weight loss of [5 lbs, No
change weight gain or weight
loss of B5 lbs, Small weight
gain of 5.1–9.9 lbs, Moderate
weight gain of 10.0–14.9 lbs,
Large weight gain of C15.0 lbs
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Other studies of premenopausal women have not fo-
cused on such short-term changes in weight. Zeigler et al.
reported weight change over 10 years was directly related
to increased risk of breast cancer for women in their 40s
and 50s [34]. For women in their 40s and hence probably
premenopausal, a 10-year weight gain of 26 or more
pounds had a relative risk of 1.35 (0.65, 2.82) compared to
no weight change. A recent case–control study of body size
and breast cancer risk in pre and postmenopausal Black
women assessed recalled change in BMI from 18 to 35 and
reported inverse relations with premenopausal breast can-
cer [5].
Repeated assessments of weight area strength of this
study. Drawing on these, we were able to model changes in
weight across the life course and construct life course
models that controlled for weight at different ages. Thus
we separated out recent weight gain from adiposity at age
18 and adult weight gain. Furthermore, the effect of weight
gain has been observed to vary by BMI and use of post-
menopausal hormone therapy in previous studies [13], is-
sues we could address with clarity in this analysis. We also
show the adverse effect of short-term weight gain is
stronger for premenopausal than postmenopausal breast
cancer, and for ER? PR- and ER-PR- breast cancer.
Of note, the previous report from the Nurses’ Health
Study cohort of adiposity and weight gain in relation to
postmenopausal breast cancer (as modified by use of hor-
mones), showed that weight gain from age 18 analyzed
through 2002 was more strongly related to risk among never
users of postmenopausal hormones [12]. This is consistent
with other studies, but we note that short-term weight gain in
postmenopausal women is independent of prior long-term
premenopausal weight gain (Online Resource 2).
Previous studies have related fasting glucose to risk of
premenopausal breast cancer. The prospective ORDET
study of women, showed a relative risk of 2.76 (1.18–6.46)
for the top versus bottom quintile of fasting glucose and
premenopausal breast cancer [35]. A meta-analysis of 10
cohort studies among non-diabetics reported significant in-
creases in risk in both premenopausal and postmenopausal
women for elevated glucose levels ([7.0 mml/L) [36].
Although the association of BMI with IGF-1 levels is non-
linear, IGF-1 increases with adiposity among normal and
overweight women, and is related to increased risk of pre-
menopausal and postmenopausal breast cancer [37]. In
postmenopausal women, BMI increases circulating estrogen
levels, that in turn are associated with increased breast cancer
risk; in contrast, in premenopausal women, BMI is generally
inversely related to estrogens and estrogens are less clearly
related to risk. These metabolic pathways provide plausible
mechanisms for weight gain to increase breast cancer risk.
Weight in this cohort is self-reported but validation
studies show it is highly correlated with independently
measured weight [3, 38] and the mean difference of self-
report and measured weight is minimal. Weight at age 18 is
reproducibly reported with little bias [31]. Consistent with
previous reports from our cohort, weight gain is greater in
premenopausal women [39].
Conclusion
Short-term weight gain, particularly during premenopausal
years and among normal weight women, adds to risk of
breast cancer.
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